Who owns INOVIO PHARMACEUTICALS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of INO from SEC Form 13F filings across 102 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 102 institutions disclosed 32.8M shares of INOVIO PHARMACEUTICALS, INC. worth $36.1M — about 40.2% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
102
13F holders
$36.1M
value, 2026 filers
40.2%
of shares outstanding (32.8M sh)
22
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of INO's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 8.5M | $9.3M | 0.0% | 10.4% | -9.5% |
| 2 | Jupiter Topco LLCNEW | 5.2M | $5.7M | 0.0% | 6.3% | new |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 3.7M | $4.0M | 0.0% | 4.5% | +25.8% |
| 4 | Boxer Capital Management, LLC | 2.8M | $3.1M | 0.2% | 3.5% | +20.0% |
| 5 | ADAR1 Capital Management, LLC | 2.1M | $2.4M | 0.1% | 2.6% | +45.8% |
| 6 | D. E. Shaw & Co., Inc. | 1.4M | $1.5M | 0.0% | 1.7% | -38.9% |
| 7 | TWO SIGMA INVESTMENTS, LP | 1.2M | $1.4M | 0.0% | 1.5% | +217.6% |
| 8 | Eversept Partners, LP | 1.0M | $1.1M | 0.1% | 1.3% | 0.0% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 802,751 | $883,749 | 0.0% | 1% | +0.2% |
| 10 | MILLENNIUM MANAGEMENT LLC | 796,107 | $875,718 | 0.0% | 1% | -43.6% |
| 11 | BlackRock, Inc. | 779,057 | $856,963 | 0.0% | 1% | +17.7% |
| 12 | VANGUARD FIDUCIARY TRUST CO | 480,769 | $528,846 | 0.0% | 0.6% | +22.6% |
| 13 | Caption Management, LLCNEW | 478,950 | $526,845 | 0.0% | 0.6% | new |
| 14 | RENAISSANCE TECHNOLOGIES LLC | 361,339 | $397,473 | 0.0% | 0.4% | -43.9% |
| 15 | STATE STREET CORP | 336,610 | $370,271 | 0.0% | 0.4% | +13.6% |
| 16 | GSA CAPITAL PARTNERS LLP | 265,011 | $292,000 | 0.0% | 0.3% | 0.0% |
| 17 | UBS Group AG | 262,320 | $288,552 | 0.0% | 0.3% | +5.1% |
| 18 | Quadrature Capital LtdNEW | 258,928 | $284,821 | 0.0% | 0.3% | new |
| 19 | CITADEL ADVISORS LLC | 241,775 | $265,952 | 0.0% | 0.3% | -15.6% |
| 20 | NORTHERN TRUST CORP | 174,394 | $191,833 | 0.0% | 0.2% | -41.6% |
| 21 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 173,000 | $190,300 | 0.0% | 0.2% | 0.0% |
| 22 | NOMURA HOLDINGS INCNEW | 150,000 | $165,000 | 0.0% | 0.2% | new |
| 23 | HRT FINANCIAL LP | 140,432 | $154,000 | 0.0% | 0.2% | +987.2% |
| 24 | DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am MainNEW | 133,648 | $147,012 | 0.0% | 0.2% | new |
| 25 | GMT Capital Corp | 126,119 | $138,731 | 0.0% | 0.2% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.